For patients with metabolic dysfunction-associated steatohepatitis and fibrosis, semaglutide is associated with improved liver histologic outcomes.

An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

More than 40,000 people in the United States are living with cystic fibrosis, a genetic disease that affects the mucous membranes in the body.

24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice ... Star-Shaped Cells That Promote Fibrosis Also Regulate Liver Health Mar. 12, 2025 — New ...

Diagnosed with Cystic Fibrosis (CF) as an infant, Francesca Mizzi has spent her life navigating the daily challenges of CF, but her story is one of strength, and a refusal to let her condition define ...

(Gut) Several genotypes are associated with fibrosis risk in patients with metabolic dysfunction-associated steatotic liver disease. (Journal of Hepatology) A randomized trial evaluated digital ...

May is Cystic Fibrosis Awareness Month - learn about this genetic condition causing thick mucus and organ damage.

Antimicrobial resistance, in which germs like bacteria and fungi no longer respond to medicines, is a rising global threat.

New drug treatments for liver fibrosis are now emerging, giving clinicians, for the first time, a means of improving liver function and slowing disease progression. The Elecsys PRO-C3 test ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical ... can lead to inflammation, liver fibrosis, cirrhosis and liver cancer ...